PTEN is one of the most frequently mutated tumor suppressor genes in human cancers. Loss of function alteration of PTEN results in increased activation of PI3K/Akt signaling, which is associated with increased proliferation, survival and neoplastic growth. Here, we have addressed the effects of conditional deletion of PTEN in hematopoietic cells. For this purpose, we have crossed PTEN conditional knock-out mice with a knock-in mouse expressing the CRE recombinase in the CD45 locus (CD45:Cre; PTEN fl/fl). CD45 is also known as leucocyte common antigen and is expressed in virtually all white cells as well as in hematopoietic stem cells. Using a reporter mice, we demonstrate that CD45:Cre mouse displays recombinase activity in both myeloid and lymphoid cells. However, CD45:Cre+/-PTENfl/fl mice develop T-Acute lymphoblastic Leukemia and Lymphoma, but no other types of hematological malignancies such as myeloproliferative disorders of B-cell lymphomas. These results indicate that conditional deletion of PTEN in hematopoietic CD45-positive cells diverts neoplastic growth to the formation of T-cell malignancies.
Introduction
PTEN (phosphatase and tensin homolog deleted on chromosome 10) encodes a dual lipid and protein phosphatase that plays a crucial role in the phosphatidylinositol-3 kinase/Akt/mammalian Target of Rapamycin (PI3K/Akt/mTOR) signaling pathway.
PTEN
dephosphorylates phosphatidylinositol-3,4,5-triphosphate (PIP3) to phosphatidylinositol-4,5-diphosphate (PIP2), thereby antagonizing the activation of the function of PI3K. 12 ( Loss of PTEN function causes the activation of PI3K/Akt signaling that leads to increased cell growth and survival. 345 PTEN is one of the most frequently mutated tumor suppressor genes in human cancers. The tumor suppressive function of PTEN was identified as the chromosome region 10q23 partially or completely deletd in multiple neoplasias. 67 Moreover, germline mutations of PTEN gene were identified in patiens with Cowden disease. 6 Loss-of-function alterations of PTEN are frequently found in solid tumors such as glioblastomas, thyroid breast, colon prostate or endometrial carcinomas 8 and in hematological malignancies including both lymphoid 9101112 and myeloid neoplasms. 131415 The PI3K/AKT/mTOR pathway has been implicated in human leukemogenesis. The role of PTEN in maintenance of hematological homeostasis has been evidenced by PTEN knock-out (KO) mouse models. Mice hemizygous for PTEN (PTEN+/-) develop multiple neoplasias, including both solid and hematological malignancies. 161718 Conditional deletion of both PTEN alleles in many cell types have been achieved by crossing conditonal PTEN floxed mice 19 with different Cre expression systems. We have recently demonstrated tamoxifen-inducible expression of Cre recombinase in epithelial cells leads to the development of thyroid, endometrial and prostate neoplasias. 20 Conditional PTEN deletion in hematological system also results in the appearance of malignancies. Tamoxifen-inducible Cre under the control of Rosa26 promoter (R26CRE:ER) causes PTEN excision in a broad spectrum of cells, leading to development of multiple neoplasias including lymphomas. 21 Lck-mediated Cre expression allows conditional deletion of PTEN in double negative thymocytes, leading to development of T-cell lymphomas. 22 Finally, by using the polyinosine-polycytidine inducible Mx1-Cre mice (Yilmaz 2006) or the VE-cadherin-Cre mice, PTEN has been successfully deletes in hematopoietic stem cells (HSC). In both mice models, animals suffer from either acute myeloid leukemia (AML) or T-acute lymphoblastic leumekina/lymphoma (T-ALL).
To date, there is no existing mouse model to achieve specific PTEN deletion in hematopoietic cells without affection of other cell types. In the present work, we have addressed the effects of conditional deletion of PTEN in CD45 expressing cells. For these purpose, we have crossed PTEN conditional knock-out mice with a knock-in mouse expressing the CRE recombinase in the CD45 locus. The resulting mouse develops T-ALL, but no other types of hematological malignancies.
Materials and methods

Ethical statement
All procedures performed in this study followed the National Institute of Health Guide for the Care and Use of Laboratory Animals and were approved by the Committee on Ethics of Animal Experiments of Universitat de Lleida/IRB Lleida (CEEA).
Mice
Mice were housed and maintained in a barrier facility, and pathogen-free procedures were used in all mouse rooms. During all the study, humane endpoints were used. Mice were monitorized every day and euthanized when they showed lethargy, ruffled fur, haunched posture or anorexia.
For this purpose, animals were anesthesized with isofluorane and sacrificed by cervival dislocation. Organs were collected and further processed for the different studies described below.
Genotyping of PTEN deletion
Genomic DNA was isolated from WT and KO spleens by standar procedures. Briefly, tissue was chopped and digested with 1mg/mL of proteinase K (Sigma, Sant Louis, MO) at 55ºC for 4 hours. Samples were boiled 5 minutes and DNA was precipitated with 100% ethanol. Standar PCR was performed using three different primers:
common forward P1 5'-ACTCAAGGCAGGGATGAGC-3', reverse P2 5'-AATCTAGGGCCTCTTGTGCC-3' and reverse P3 5'-GCTTGATATCGAATTCCTGCAGC-3'. PCR products were resolved in agarose gels and visualized by ethidium bromide staining.
Western blot analysis
Spleens were washed with PBS, frozen in liquid nitrogen and homogenized in ice with lysis buffer (2% sodium dodecyl sulfate, 125 mmol/L Tris-HCl, pH 6.8). Samples were boiled for 5 minutes at 95ºC, sonicated for 30 seconds and centrifuged (10 minutes at 15000 rpm). Supernatants were recovered and protein concentrations were determined with a protein assay kit (Bio-Rad, Hercules, CA). Equal amounts of proteins were subjected to SDS-PAGE and transferred to PVDF membranes (Millipore). Appropriate negative controls were also tested. Representative images were taken with a Leica DMD 108 microscope.
Hematoxilyn and Eosin (H&E) stained samples were histologically reviewed and evaluated by two pathologists, following uniform pre-established criteria
Cytological analysis
Blood was collected from the submandibular vein and smears were immediately prepared and fixed in 100% ethanol. For diff-quick staining, slides were fixed with Diff-Quick fixative reagent and stained with Diff-Quick solution I (eosinophilic) and Diff-Quick solution II (basophilic) before being brought to destilled water, air dried and mounted.
For Papanicolau stain, ethanol fixed slides were stained with hematoxylin and counterstained with Orange G and Eosin Azure (EA50), cleaned with 95% ethanol and mounted.
Proliferation analysis
50 high power microscope fields were examined for mitotic figures and counted.
Ki-67 staining was used to asses the index of proliferation of splenic cells in KO and WT mice. Five representative fields of each tissue were photographed for each animal.
Proliferation was calculated as the percentage of Ki-67 positive nuclei to the total number of nuclei of each field (1000-2000 total nuclei were evaluated for each animal).
Counting was performed using ImageJ software (WayneRasband, NIH, Bethesda, MD).
FACS
Blood was collected from the submandibular vein in heparinized capillars. Bone marrow cells were obtained from the long bones (tibias and femurs). After cleaning them from adherent soft tissue, the tip of each bone was removed and the marrow was For the reporter CD45:Cre mT/mG mice analysis, blood and BM were collected as described and green/red fluorescences were analysed.
Fluorescence emission was measured using FACSCalibur (BD Biosciences, San Jose, CA, USA)
CD45:Cre reporter assays
For reporter assays of the cre activity, CD45:Cre+/-and mT/mG+/+ mice were bred.
The resulting offspring was weaned and genotyped. One month after birth, CreER+/-mT/mG+/-mice were sacrified and organs were collected and fixed in 4% PFA for 4
hours at room temperature. Samples were cryoprotected in PBS with 30% sucrose overnight at 4ºC and embedded in OCT (VWR International). 8-μm sections of frozen tissue were cut with cryostat and nuclei were counterstained with Hoescht and samples mounted with PBS:glycerol (1:1).
Tissue immunofluorescence was visualized and analyzed using a confocal microscope (Olympus, Tokyo, Japan). Confocal images were edited using FluoView software (Olympus).
Statistical analysis
Experiments were performed at least three times and statistical significance was determined by Student's test with p-value ≤0.05 (*); p-value ≤0.01 (**) or p-value ≤0.001(***).
Results
Generation of conditional mouse model to delete PTEN in CD45-expressing cells
To achieve conditional deletion of the two PTEN alleles in CD45 expressing cells, conditional PTEN knock-out mouse (PTENfl/fl) 19 was crossed with a knock-in mouse expressing Cre recombinase into the CD45 locus (CD45:Cre) 23 We fist evaluated the effects of conditional deletion of the two PTEN alleles in mice lifespan (Fig.1A) . Kaplan-Meier analysis of mice survival revealed that none of the mice such as the thymus and the lymph nodes ( Fig. 1B) . To demonstrate Cre mediated recombination of PTEN in lymphoid organs, we performed genotyping and western blot analysis of the spleen from one WT mouse and two KO littermates ( Fig 1C) .
Genotyping demonstrated the presence of an amplified band corresponding to the recombined allele in KO mice. Accordingly, western blot analysis confirmed complete loss of PTEN expression and increased Akt phosphorylation in KO mice ( Fig 1D) .
Deletion of PTEN in CD45.expressing cells leads to development of diffuse peripheral lymphomas/leukemias
As mentioned above, macroscopic evaluation evidenced a marked increase of Histopathological analysis of other organs demonstrated atypical lymphoid cells lacking PTEN infiltrating in kidneys, live, lungs, colon or ovary (Fig. 3A) . Moreover, flow cytometer analysis and peripheral blood extension from WT and KO mice revealed a dramatic increase of lymphocyte population (Fig 3B, 3C) . These results suggest that deletion of PTEN in CD45 expressing cells results in development of severe leukemia/lymphomas.
CD45:Cre+/-PTENfl/fl mice develp T-cell but not B-cell lymphomas
Next, we investigated the nature of lymphomas observed in CD45:Cre+/-PTENfl/fl mice. For this purpose, we performed flow cytometry analysis using B220 and anti-TCR antibodies to differentiate B-lymphocytes from T-lymphocytes. Analysis of bone marrow, blood and spleen samples obtained from WT and KO mice revealed a marked decrease of B lymphocytes and an increased population of T-cells in KO mice ( Fig 4A) ,
suggesting that the malignancies developed by KO mice were compatible with T-cell lymphoma. To further demonstrate T-cell nature of lymphomas, we carried out immunohistochemical analysis of KO spleens, lymph nodes and bone marrow with anti-CD3 antibodies, which specifically recognize T cells. In WT mice, CD3+ cells location was restricted to paracortical zone of lymph nodes and the periarteriolar lymphoid sheath of the spleen (Fig 4B) . In contrast in KO mice, bone marrow, as well as the germinal centers of both lymph nodes and spleens, were invaded by CD3+ cells.
To address the presence of remaining myeloid cells in these tissues, we performed immunostaining of myeloperoxidase (MPO) in all of them. As expected, due to the increase in the lymphoid population, PTEN deletion caused a marked decrease of myeloperoxidase expressing cells. (Fig 4C) Accordingly to the described results, lymphocytic infiltrates found in liver, lung, kidney or colon, were positive for CD3 staining (Fig 4D) . Immunohistochemistry analysis of blood extensions also revealed an increase of CD3 expressing cells in peripheral blood Fig 5A) , suggesting that Cre activity was able to induce recombination in both cell populations. These results were further confirmed by confocal microscopy analysis of peripheral blood and bone marrow extensions, as well as spleen and lymph node sections. In all those tissues, we observed the presence of green lymphocytes and granulocytes ( Fig 5B) . The evidences indicate that, as expected, the expression and activity of Cre recombinase under the control of CD45
promoter was able to cause recombination in all blood lineages, although the efficiency was higher in lymphoid cells than in myeloid populations.
Discussion
In the present report, we have investigated the effects of conditional deletion of PTEN in hematopoietic cells. To date, there is no existing mouse model to achieve deletion of PTEN exclusively in hematopoietic cells, but not in other cell types. For this purpose, we have crossed a previously described knock-in mouse expressing Cre recombinase in CD45 locus 23 Regarding the first question, we considered the possibility that PTEN was not deleted in myeloid cells because Cre recombinase was not efficiently expressed in this lineage.
However, using mT/mG reporter mice, we have demonstrated Cre recombination in both myeloid and lymphoid cells. Although these results suggest that loss of PTEN in hematopoietic cells favors the formation of lymphoid malignancies, we cannot rule out the possibility that the differences observed are affected by differences in the efficiency of recombination, which is lower in the myeloid lineage. Two previous studies have demonstrated that PTEN expression is required to maintain HSCs and participates in lineage choice and leukemogenesis. 2526 . The use of Mx1-Cre mice for PTEN ablation leads to a rapid formation of myeloproliferative disease (MPD) that mainly progresses to acute myeloid leukemia (AML) 2526 On the other hand, the use of the VE-cadherincre mice for PTEN excision has been reported to cause T-ALL in 74% of the animals analyzed. 27 It is important to note that in the first model, PTEN is silenced in adult mice, while in the second one it occurs at the fetal level. In this sense, our model is closer to the VE-cadherin-cre mice, as CD45 is expressed already in the fetal state of hematopoiesis and we observe T-ALL but not any myeloid leukemia. These facts suggest that the outcome of the mutation can be affected not only by the tissue where it happens, but also the moment when it occurs. Another point to take into account is the fact that neither Mx1-Cre nor VE-cadherin-cre mice delete PTEN exclusively in hematopoietic cells. We report the first study where PTEN has been knocked in all the hematopoietic system since its very beginning without affecting other cell types and avoiding stimulation of the system with inducers as IFN, which has been reported to modulate hematopoiesis. 28 Regarding the second question, is worth to mention that the vast majority of lymphoid neoplasms are of B-cell origin (85-90%), with most of the remainder being T cell tumors. 29 Membranes were reproved with tubulin to ensure protein loading. 
